Page last updated: 2024-12-05

3-chloropropionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-chloropropionic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7899
CHEMBL ID1990700
SCHEMBL ID139248
MeSH IDM0049935

Synonyms (56)

Synonym
AC-16131
3-chloro-propionic acid
nsc-2183
nsc2183
NCI60_001817
3-chloropropanic acid
einecs 203-534-4
beta-monochloropropionic acid
nsc 174
hsdb 2053
brn 1098495
beta-chloropropionic acid
ai3-22338
inchi=1/c3h5clo2/c4-2-1-3(5)6/h1-2h2,(h,5,6
propionic acid, 3-chloro-
107-94-8
nsc174
wln: qv2g
nsc-174
3-chloropropionic acid
3-chloropropanoic acid
propanoic acid, 3-chloro-
.beta.-chloropropionic acid
.beta.-monochloropropionic acid
3-chloropropionic acid, 98%
AKOS005287338
NCGC00248950-01
ccris 9440
unii-r5j180fn9z
r5j180fn9z ,
ec 203-534-4
l-(-)-2-chloro proxic acid
dtxsid5021546 ,
dtxcid701546
cas-107-94-8
NCGC00258737-01
tox21_201185
BBL012215
STL163556
FT-0615518
.beta.-chloropropionic acid [mi]
3-chloropropionic acid [hsdb]
SCHEMBL139248
CHEMBL1990700
r-chloropropionate
chloromethyl acetic acid
W-108731
F2191-0212
mfcd00002764
VS-03236
Q223070
3-chloropropionic--d4 acid
CS-0165952
3-chloropropanoic acid? (brexpiprazole impurity pound(c)
EN300-24953
Z203045320
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency61.93960.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency52.64090.000221.22318,912.5098AID743035; AID743063
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency31.04330.003041.611522,387.1992AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency55.20370.001530.607315,848.9004AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency61.93960.005428.02631,258.9301AID1346982
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency1.56890.023723.228263.5986AID743223
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency39.08130.001723.839378.1014AID743083
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (4)

Processvia Protein(s)Taxonomy
lactate transmembrane transportMonocarboxylate transporter 4Homo sapiens (human)
pyruvate catabolic processMonocarboxylate transporter 4Homo sapiens (human)
pyruvate transmembrane transportMonocarboxylate transporter 4Homo sapiens (human)
monocarboxylic acid transportMonocarboxylate transporter 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
RNA bindingMonocarboxylate transporter 4Homo sapiens (human)
protein bindingMonocarboxylate transporter 4Homo sapiens (human)
monocarboxylic acid transmembrane transporter activityMonocarboxylate transporter 4Homo sapiens (human)
lactate:proton symporter activityMonocarboxylate transporter 4Homo sapiens (human)
pyruvate transmembrane transporter activityMonocarboxylate transporter 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
plasma membraneMonocarboxylate transporter 4Homo sapiens (human)
membraneMonocarboxylate transporter 4Homo sapiens (human)
basolateral plasma membraneMonocarboxylate transporter 4Homo sapiens (human)
apical plasma membraneMonocarboxylate transporter 4Homo sapiens (human)
lateral plasma membraneMonocarboxylate transporter 4Homo sapiens (human)
nuclear membraneMonocarboxylate transporter 4Homo sapiens (human)
plasma membraneMonocarboxylate transporter 4Homo sapiens (human)
basolateral plasma membraneMonocarboxylate transporter 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID681140TP_TRANSPORTER: uptake in Xenopus laevis oocytes2000The Journal of physiology, Dec-01, Volume: 529 Pt 2Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's3 (20.00)18.2507
2000's4 (26.67)29.6817
2010's4 (26.67)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.70 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index63.04 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]